Tekla Capital Management LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q2 2023$457,346
+0.6%
98,3540.0%0.02%
+5.9%
Q1 2023$454,395
-61.9%
98,354
-33.3%
0.02%
-62.2%
Q4 2022$1,192,050
+31.0%
147,531
-10.0%
0.04%
+21.6%
Q3 2022$910,000
+6.6%
163,9240.0%0.04%
+8.8%
Q2 2022$854,000
-36.6%
163,9240.0%0.03%
-27.7%
Q1 2022$1,347,000
-72.4%
163,924
-50.0%
0.05%
-70.1%
Q4 2021$4,878,000
-35.5%
327,850
-18.1%
0.16%
-35.4%
Q3 2021$7,559,000
+1.6%
400,1470.0%0.24%
+0.4%
Q2 2021$7,439,000
-43.0%
400,147
-30.3%
0.24%
-46.1%
Q1 2021$13,060,000
-14.4%
573,823
-18.3%
0.45%
-16.2%
Q4 2020$15,252,000
+136.6%
702,523
+9.6%
0.54%
+121.5%
Q3 2020$6,445,000
+29.5%
641,2680.0%0.24%
+28.0%
Q2 2020$4,976,000
-23.9%
641,2680.0%0.19%
-36.1%
Q1 2020$6,541,000
-7.3%
641,2680.0%0.30%
+10.9%
Q4 2019$7,054,000
+21.0%
641,2680.0%0.27%
+5.1%
Q3 2019$5,829,000
-20.1%
641,2680.0%0.25%
-14.8%
Q2 2019$7,298,000
-0.1%
641,2680.0%0.30%
+0.3%
Q1 2019$7,304,000
+252.2%
641,268
+178.9%
0.30%
+233.7%
Q4 2018$2,074,000
-44.7%
229,900
-8.0%
0.09%
-34.6%
Q3 2018$3,750,000250,0000.14%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders